These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 22409886

  • 21. Declining responsiveness to influenza vaccination with progression of human pregnancy.
    Schlaudecker EP, Ambroggio L, McNeal MM, Finkelman FD, Way SS.
    Vaccine; 2018 Jul 25; 36(31):4734-4741. PubMed ID: 29941326
    [Abstract] [Full Text] [Related]

  • 22. Smoking and serological response to influenza vaccine.
    Choi WS, Nowalk MP, Moehling Geffel K, Susick M, Saul S, Lin CJ, Ross TM, Zimmerman RK.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2404752. PubMed ID: 39400298
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of the trivalent influenza vaccination in Thai patients with hemodialysis or kidney transplant compared with healthy volunteers.
    Krairittichai U, Chittaganpitch M.
    J Med Assoc Thai; 2013 Mar 31; 96 Suppl 3():S1-7. PubMed ID: 23682516
    [Abstract] [Full Text] [Related]

  • 24. The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.
    Lin SY, Wu ET, Lin CH, Shyu MK, Lee CN.
    PLoS One; 2013 Mar 31; 8(6):e62983. PubMed ID: 23762229
    [Abstract] [Full Text] [Related]

  • 25. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
    Sindoni D, La Fauci V, Squeri R, Cannavò G, Bacilieri S, Panatto D, Gasparini R, Amicizia D.
    J Prev Med Hyg; 2009 Jun 31; 50(2):121-6. PubMed ID: 20099444
    [Abstract] [Full Text] [Related]

  • 26. Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season.
    Ganczak M, Dubiel P, Drozd-Dąbrowska M, Hallmann-Szelińska E, Szymański K, Brydak LB.
    Int J Environ Res Public Health; 2019 Nov 14; 16(22):. PubMed ID: 31739554
    [Abstract] [Full Text] [Related]

  • 27. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn.
    Blanchard-Rohner G, Meier S, Bel M, Combescure C, Othenin-Girard V, Swali RA, Martinez de Tejada B, Siegrist CA.
    Pediatr Infect Dis J; 2013 Dec 14; 32(12):1374-80. PubMed ID: 24569309
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM, Santini-Oliveira M, Martorelli A, Luz PM, Vasconcellos MT, Giacoia-Gripp CB, Morgado M, Nunes EP, Lemos AS, Ferreira AC, Moreira RI, Veloso VG, Siqueira M, Grinsztejn B, Camacho LA.
    J Med Virol; 2016 Mar 14; 88(3):426-36. PubMed ID: 26267817
    [Abstract] [Full Text] [Related]

  • 29. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth JK, Domegan L, Pitigoi D, Machado A, Paradowska-Stankiewicz IA, Bella A, Larrauri A, Ferenczi A, Joan O´Donell, Lazar M, Pechirra P, Korczyńska MR, Pozo F, Moren A, I-MOVE multicentre case-control team.
    Euro Surveill; 2016 Mar 14; 21(7):pii=30139. PubMed ID: 26924024
    [Abstract] [Full Text] [Related]

  • 30. Immune response to influenza vaccination in children with cancer.
    Doganis D, Kafasi A, Dana H, Spanakis N, Baka M, Pourtsidis A, Sdogou T, Vintila A, Rafailidou V, Chantzi P, Servitzoglou M, Bouhoutsou D, Varvoutsi M, Kosmidis H, Tsolia M.
    Hum Vaccin Immunother; 2018 Mar 14; 14(9):2310-2317. PubMed ID: 29708816
    [Abstract] [Full Text] [Related]

  • 31. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
    Loebermann M, Anders G, Brestrich G, Fritzsche C, Klammt S, Boršo D, Frimmel S, Riebold D, Reisinger EC.
    Vaccine; 2011 Feb 01; 29(6):1228-34. PubMed ID: 21167116
    [Abstract] [Full Text] [Related]

  • 32. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC.
    J Med Virol; 2009 May 01; 81(5):908-14. PubMed ID: 19319953
    [Abstract] [Full Text] [Related]

  • 33. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.
    Agrati C, Castilletti C, Cimini E, Lapa D, Quartu S, Caglioti C, Lanini S, Cattoli G, Martini F, Ippolito G, Capobianchi MR.
    PLoS One; 2014 May 01; 9(8):e105651. PubMed ID: 25162670
    [Abstract] [Full Text] [Related]

  • 34. Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial.
    deBruyn J, Fonseca K, Ghosh S, Panaccione R, Gasia MF, Ueno A, Kaplan GG, Seow CH, Wrobel I.
    Inflamm Bowel Dis; 2016 Mar 01; 22(3):638-47. PubMed ID: 26595551
    [Abstract] [Full Text] [Related]

  • 35. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U, Wongsurakiat P, Pooruk P, Maranetra N, Puthavathana P.
    Viral Immunol; 2010 Jun 01; 23(3):329-34. PubMed ID: 20565296
    [Abstract] [Full Text] [Related]

  • 36. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study.
    Van Ermen A, Hermanson MP, Moran JM, Sweitzer NK, Johnson MR, Vardeny O.
    Eur J Heart Fail; 2013 May 01; 15(5):560-4. PubMed ID: 23291729
    [Abstract] [Full Text] [Related]

  • 37. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
    Manuel O, Humar A, Berutto C, Ely L, Giulieri S, Lien D, Meylan PR, Weinkauf J, Pascual M, Nador R, Aubert JD, Kumar D.
    J Heart Lung Transplant; 2011 Jun 01; 30(6):679-84. PubMed ID: 21377898
    [Abstract] [Full Text] [Related]

  • 38. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers.
    Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, Levartovsky D, Litinsky I, Kaufman I, Wigler I, Mendelson E, Elkayam O.
    Ann Rheum Dis; 2006 Feb 01; 65(2):191-4. PubMed ID: 16014674
    [Abstract] [Full Text] [Related]

  • 39. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay J, Fonseca K, Charest H, Krajden M, Petric M, Mahmud SM, Van Caeseele P, Bastien N, Eshaghi A, Li Y.
    J Infect Dis; 2015 Sep 01; 212(5):726-39. PubMed ID: 25784728
    [Abstract] [Full Text] [Related]

  • 40. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT, Guo CY, Tsai MS, Cheng YY, Lin MT, Chen CH, Shen D, Wang JR, Sung JM.
    Vaccine; 2012 Jul 13; 30(33):5009-18. PubMed ID: 22658967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.